Informational purposes only, not investment advice.
MKKGY (MKKGY)
tormere.com/research/MKKGY · generated 2026-10-28
$32.25
+0.53%
General Information
Price$32.25
Change+0.53%
Market Cap—
SectorHealth Care
IndustryPharmaceuticals
Exchange—
Beta (raw, 60mo vs SPY)0.96
Signals
Insider Velocity—
Congress Trades (90d)—
Short Volume
—
Conviction Score—
Price Chart (1 Year)
Recent News
ProtaGene Appoints Former Merck KGaA CDMO Leader Matthias Bucerius as Chief Executive Officer — Yahoo · 2026-10-27
Stocktwits Biotech Dealmaker: Gilead And Roche Double Down On Early-Stage Assets Over Full Buyouts This Week — Yahoo · 2026-10-24
Global Peptide Synthesis Market Forecast to 2031: Size, Share, Trends, and Growth | GLP-1 Boom Lifts Demand for Peptide Synthesis — Yahoo · 2026-10-22
Global Bioprocessing Reagent Market Report 2026 | Capitalize on 12.3% CAGR as Thermo Fisher, Danaher, Merck KGaA and Sartorius Accelerate AI and Single-Use Systems — Yahoo · 2026-10-21
Global Human Osteoblasts Market Report 2026 | Capitalize on $53.09 Billion Revenue Share by 2030 as Merck KGaA, Thermo Fisher Scientific, Lonza and STEMCELL Lead the Industry — Yahoo · 2026-10-21
Tormere — informational purposes only, not investment advice.
